Short-lasting headache syndromes and treatment options

Current Pain and Headache Reports

Volumn 8, Issue 4, 2004, Pages 268-273

  Rozen, Todd D ^a  

^a Michigan Head Pain and Neurological Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ATENOLOL; CAFFEINE; CARBAMAZEPINE; CELECOXIB; CLONAZEPAM; CYCLOBENZAPRINE; ERGOTAMINE; FLUNARIZINE; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MELATONIN; MISOPROSTOL; NAPROXEN; OXYGEN; PARACETAMOL; PIROXICAM; PREDNISONE; PROSTAGLANDIN; PROTON PUMP INHIBITOR; ROFECOXIB; SUMATRIPTAN; TOPIRAMATE; UNINDEXED DRUG; VERAPAMIL;

CLINICAL PRACTICE; CLUSTER HEADACHE; CONJUNCTIVA DISEASE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM ULCER; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG STRUCTURE; DYSPEPSIA; EXPLODING HEAD SYNDROME; GASTROINTESTINAL DISEASE; HEADACHE; HORNER SYNDROME; HUMAN; LACRIMATION; MEDICAL DECISION MAKING; MIGRAINE; NEURALGIA; NOSE CONGESTION; PHOTOPHOBIA; PHYSICIAN; PTOSIS; REVIEW; RHINORRHEA; SYMPTOM; TREATMENT FAILURE;

EID: 4344579026     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-004-0006-z     Document Type: Review

References (34)

1. Sjaastad O, Dale I: Evidence for a new (?) treatable headache entity. Headache 1974,14:105-108.
2. Antonaci F, Sjaastad O: Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989, 29:648-656.
3. Sjaastad O, Stovner LJ, Stolt-Nielsen A, et al.: CPH and hemicrania continua: requirements of high indomethacin dosages. An ominous sign? Headache 1995, 35:363-367.
4. Boes CJ, Dodick DW: Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002, 42:699-708.
5. Mathew NT, Kailasam J, Fischer A: Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000, 55:316.
6. Rozen TD: High-dose celecoxib and rofecoxib in the treatment of hemicrania continua. Neurology 2002, 58(suppl 3):A471.
7. Evers S, Husstedt IW: Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996, 36:429-432.
8. Goadsby PJ, Edvinsson L: Neuropeptide changes in a case of chronic paroxysmal hemicrania: evidence for trigeminal parasympathetic activation. Cephalalgia 1996, 16:448-450.
9. Raskin NH: The hypnic headache syndrome. Headache 1988, 28:534-536.
10. Dodick DW, Mosek AC, Campbell JK The hypnic ("alarm clock") headache syndrome. Cephalalgia 1998, 18:152-156.
11. Sibon I, Chorayeb I, Henry P: Successful treatment of hypnic headache syndrome with acetazolamide. Neurology 2003, 61:1157-1158.
12. Pinessi L, Rainero, I, Cicolin A, et al.: Hypnic headache syndrome: association of the attacks with REM sleep. Cephalalgia 2003, 23:150-154.
13. Evers S, Rahmann A, Schwaag S, et al.: Hypnic headache: the first German cases including polysomnography. Cephalalgia 2003, 23:20-23.
14. Pearce JM: Clinical features of the exploding head syndrome. J Neurol Neurosurg Psychiatry 1989, 52:907-910.
15. Pearce JM: Exploding head syndrome. Lancet 1988, 2:270-271.
16. Sachs Q Svanborg E: The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep 1991, 14:263-266.
17. Ertsey C, Jelencsik I: Cough headache associated with Chiari type-I malformation: responsiveness to indomethacin. Cephalalgia 2000, 20:518-520.
18. Raskin NH: The cough headache syndrome: treatment. Neurology 1995, 45:1784.
19. Sjaastad O, Russell D, Horven I, Bunaes U: Multiple neuralgiform unilateral headache attacks associated with conjunctival injection and appearing in dusters: a nosological problem. Proceedings of the Scandinavian Migraine Society 1978, 31.
20. Sjaastad O, Saunte C, Salvesen R: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia 1989, 9:147-156.
21. Pareja JA, Sjaastad O: SUNCT syndrome in the female. Headache 1994, 34:217-220.
22. Pareja JA, Caballero V, Sjaastad O: SUNCT syndrome: status-like pattern. Headache 1996, 36:622-624.
23. Pareja JA, Sjaastad O: SUNCT syndrome: a clinical review. Headache 1997, 47:195-202.
24. Trucco M, Mainardi F, Maggioni F, et al.: Chronic paroxysmal hemicrania, hemicrania continua, and SUNCT syndrome in association with other pathologies: a review. Cephalalgia 2004, 24:173-184.
25. Goadsby PJ, Lipton RB: A review of paroxysmal hemicranias, SUNCT syndrome, and other short-lasting headaches with autonomic features, including new cases. Brain 1997, 120:193-209.
26. D'Andrea G, Granella F, Ghiotto N, Nappi G: Lamotrigine in the treatment of SUNCT syndrome. Neurology 2001, 57:1723-1725.
27. Porta-Etessam J, Martinez-Salio A, Berbel A, Benito-Leon J: Gabapentin (Neurontin) in the treatment of SUNCT syndrome. Cephalalgia 2002, 22:249.
28. Rossi P, Cesarino F, Faroni J, et al.: SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 2003, 23:998-1000.
29. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1-96.
30. Piovesan EJ, Zukerman E, Kowacs PA, Werneck LC: COX-2 inhibitor for the treatment of idiopathic stabbing headache secondary to cerebrovascular diseases. Cephalalgia 2002, 22:197-200.
31. Dodick DW: Indomethacin-responsive headache syndromes: a hypothesis on the mechanisms underlying the efficacy of indomethacin in these disorders [Abstract]. Neurology 1999, 52:A210.
32. Peres MP, Stiles MA, Oshinsky M, Rozen TD: Remitting form of hemicrania continua with seasonal pattern. Headache 2001, 41:592-594.
33. El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, et al.: Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res 2002, 46:235-243.
34. Rozen TD: Melatonin as treatment for idiopathic stabbing headache. Neurology 2003, 61:865-866.